Cardiovascular Imaging in the Era of Molecular Medicine: Nov. 29, 8:30am-12:00pm

This multisession course considers the clinical potential of molecular imaging in management of cardiovascular diseases. Experts review molecular methods for imaging plaque, stem cell labeling for noninvasive imaging, the future of cardiovascular molecular imaging and more.

When: Tuesday, Nov. 29, 8:30-12:00
Where: S502AB

Speaker information:

King C. Li, MD, director, department of translational imaging, Methodist Hospital Research Institute, Houston
Zahi Fayad, PhD, director, Translational and Molecular Imaging Institute, Mount Sinai Medical Center, New York City
Farouc Jaffer, MD, PhD, director, cardiovascular molecular imaging program, Massachusetts General Hospital, Boston

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.